A model of bi-mode transmission dynamics of hepatitis C with optimal control

Mudassar Imran1, Hassan Rafique, Adnan Khan

  • 1Lahore University of Management Sciences, Sector U DHA, Lahore, Pakistan, mudassar.imran@lums.edu.pk.

Insights

This study models hepatitis C virus (HCV) transmission, finding disease eradication depends on the basic reproduction number. An optimal quarantine strategy is developed to minimize persistent HCV infections.

Area of Science:

  • Epidemiology
  • Mathematical Biology
  • Public Health

Background:

  • Hepatitis C virus (HCV) poses a significant public health challenge.
  • Dominant transmission routes include unsafe blood transfusions and intravenous drug use.
  • Mathematical modeling is crucial for understanding disease dynamics and control.

Purpose of the Study:

  • To develop and analyze a deterministic mathematical model for HCV transmission.
  • To identify key factors determining HCV eradication or persistence.
  • To design and evaluate an optimal quarantine strategy for minimizing chronic infections.

Main Methods:

  • Deterministic modeling of HCV transmission dynamics.
  • Analysis of disease-free and endemic equilibria based on the basic reproduction number (R(c)).
  • Uncertainty and sensitivity analyses of model parameters.
  • Application of Pontryagin's Maximum Principle for optimal quarantine control.

Main Results:

  • HCV eradication is achieved when the basic reproduction number (R(c)) is less than 1.
  • Disease persistence is observed when R(c) is greater than 1.
  • An optimal time-dependent quarantine strategy effectively minimizes persistent HCV infections.

Conclusions:

  • The basic reproduction number (R(c)) is a critical determinant of HCV's epidemiological fate.
  • Mathematical modeling provides valuable insights into HCV transmission and control.
  • Optimal quarantine strategies can significantly reduce the burden of chronic hepatitis C infections.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
398
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
25
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.5K
Pharmacodynamic Models: Linear Concentration–Effect Model01:15

Pharmacodynamic Models: Linear Concentration–Effect Model

The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing...
91
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
159